Search Results

Pharmacotherapy of intraocular pressure - part II. Carbonic anhydrase inhibitors, prostaglandin analogues and prostamides

Authors: Costagliola, Ciro; dell'Omo, Roberto; Romano, Mario R; Rinaldi, Michele; Zeppa, Lucia; Parmeggiani, Francesco

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 17, December 2009 , pp. 2859-2870(12)

Publisher: Informa Healthcare

Pharmacotherapy of intraocular pressure: part I. Parasympathomimetic, sympathomimetic and sympatholytics

Authors: Costagliola, Ciro; dell'Omo, Roberto; Romano, Mario R; Rinaldi, Michele; Zeppa, Lucia; Parmeggiani, Francesco

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 16, November 2009 , pp. 2663-2677(15)

Publisher: Informa Healthcare

Prostanoids for the management of glaucoma

Authors: Arranz-Marquez, Esther; Teus, Miguel A

Source: Expert Opinion on Drug Safety, Volume 7, Number 6, November 2008 , pp. 801-808(8)

Publisher: Informa Healthcare

GASTROINTESTINAL ENDOCANNABINOID SYSTEM: MULTIFACETED ROLES IN THE HEALTHY AND INFLAMED INTESTINE

Author: Smid, Scott D

Source: Clinical and Experimental Pharmacology and Physiology, Volume 35, Number 11, November 2008 , pp. 1383-1387(5)

Publisher: Blackwell Publishing

Fixed-combination and emerging glaucoma therapies

Authors: Woodward, David F; Chen, June

Source: Expert Opinion on Emerging Drugs, Volume 12, Number 2, May 2007 , pp. 313-327(15)

Publisher: Informa Healthcare

A comparison of the safety and intraocular pressure lowering of bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in patients with open-angle glaucoma

Authors: Martinez, Antonio; Sanchez, Manuel

Source: Current Medical Research and Opinion, Volume 23, Number 5, May 2007 , pp. 1025-1032(8)

Publisher: Informa Healthcare

Intraocular pressure lowering effect of dorzolamide/timolol fixed combination in patients with glaucoma who were unresponsive to prostaglandin analogs/prostamides

Authors: Martínez, Antonio; Sánchez, Manuel

Source: Current Medical Research and Opinion, Volume 23, Number 3, March 2007 , pp. 595-599(5)

Publisher: Informa Healthcare

Clinical pharmacology of bimatoprost

Author: Cantor, Louis B

Source: Expert Opinion on Drug Metabolism and Toxicology, Volume 1, Number 1, 1 June 2005 , pp. 151-157(7)

Publisher: Informa Healthcare

Contact dermatitis from topical bimatoprost

Authors: Sodhi P.K.; Verma L.; Ratan S.K.

Source: Contact Dermatitis, Volume 50, Number 1, January 2004 , pp. 50-50(1)

Publisher: Blackwell Publishing

Metabolic Fate of Endocannabinoids

Authors: Stelt Mario v.d.; Marzo Vincenzo D.

Source: Current Neuropharmacology, Volume 2, Number 1, January 2004 , pp. 37-48(12)

Publisher: Bentham Science Publishers

Granulomatous anterior uveitis associated with bimatoprost

Author: Parentin F.

Source: Ocular Immunology and Inflammation, Volume 11, Number 1, March 2003 , pp. 67-71(5)

Publisher: Taylor and Francis Ltd

Bimatoprost: a member of a new class of agents, the prostamides, for glaucoma management

Author: Cantor L.B.

Source: Expert Opinion on Investigational Drugs, Volume 10, Number 4, April 2001 , pp. 721-731(11)

Publisher: Informa Healthcare

Six-Month Comparison of Bimatoprost Once-Daily and Twice-Daily with Timolol Twice-Daily in Patients with Elevated Intraocular Pressure

Authors: Sherwood M.; Brandt J.; for the Bimatoprost Study Groups 1 and 2

Source: Survey of Ophthalmology, Volume 45, Supplement 4, May 2001 , pp. 361-368(8)

Publisher: Elsevier

The Pharmacology of Bimatoprost (Lumigan&unknown;)

Authors: Woodward D.F.; Krauss A.H.-P.; Chen J.; Lai R.K.; Spada C.S.; Burk R.M.; Andrews S.W.; Shi L.; Liang Y.; Kedzie K.M.; Chen R.; Gil D.W.; Kharlamb A.; Archeampong A.; Ling J.; Madhu C.; Ni J.; Rix P.; Usansky J.; Usansky H.; Weber A.; Welty D.; Yang W.; Tang-Liu D.D.-S.; Garst M.E.; Brar B.; Wheeler L.A.; Kaplan L.J.

Source: Survey of Ophthalmology, Volume 45, Supplement 4, May 2001 , pp. 337-345(9)

Publisher: Elsevier